Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.55 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.55 |
| ▸ | PGR | P06401 | 1/20 | 0.55 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.47 |
| ▸ | F7 | P08709 | 3/20 | 0.47 |
| ▸ | F3 | P13726 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1627822 | 1.00 | ADORA3 (0.55) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL999549 | 1.00 | ADORA3 (0.55) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL9069446 | 0.87 | ALDH1A1 (0.61) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL9070079 | 0.87 | ALDH1A1 (0.61) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL6945280 | 0.86 | ADORA3 (0.44) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL28231787 | 0.86 | ADORA3 (0.44) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL6945278 | 0.86 | ADORA3 (0.44) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL6951405 | 0.86 | ATM (0.48) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL6951408 | 0.86 | ATM (0.48) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL999551 | 0.85 | ADORA3 (0.53) | ADORA3NR1I2PTGS2PGRPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | claimed |
| CN-116507709-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| US-11603506-B2 | Product comprising a plastic container and a substance composition | SYMRISE AG (DE) | 2023-03-14 | — | — | US | claimed |
| CN-115666494-A | Encapsulated compositions comprising core-shell microcapsules and methods of making the same | 奇华顿股份有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115551986-A | Fragrance composition | 奇华顿股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-109689848-B | Fragrance composition | 奇华顿股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-115297822-A | Consumer product comprising a plurality of microcapsules defined by an average total surface area | 奇华顿股份有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-110769805-B | Novel fragrance compositions and products having mood enhancing effect | 西姆莱斯有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-108601958-B | Pro-fragrance compositions | 爱客多有限公司 | 2022-06-17 | — | — | CN | claimed |
| US-20200172830-A1 | BLENDS CONTAINING ENANTIOMERICALLY PURE AMBROCENIDE® | SYMRISE AG (DE) | 2020-06-04 | — | — | US | claimed |
| US-20170114299-A1 | New mixtures having (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole)(Ambrocenide®) | SYMRISE AG (DE) | 2017-04-27 | — | — | US | claimed |
| US-20100287710-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2010-11-18 | — | — | US | claimed |
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| CN-117836397-A | Smell cancellation | 奇华顿股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-111836667-B | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| US-7538149-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2009-05-26 | — | — | US | disclosed |
| EP-1967579-A1 | LIQUID DETERGENT | Kao Corporation (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-20060258776-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. | 2006-11-16 | — | — | US | disclosed |
| EP-1721943-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172830-A1 | BLENDS CONTAINING ENANTIOMERICALLY PURE AMBROCENIDE® | OR51E2, CYP1B1, QDPR | ADORA3 1270/4885NR1I2 1223/4885PTGS2 1499/4885 |
| US-20170114299-A1 | New mixtures having (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole)(Ambrocenide®) | OR51E2, OR10J3, TAS2R7 | ADORA3 469/4885NR1I2 1321/4885PTGS2 3609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.